Amending Decision No 1313/2013/EU on a Union Civil Protection Mechanism (Motion adopted): 617 For, 52 Against, 23 Abstention, 150 Did not vote (842 Members). Ewa Kopacz: For.

EU-African security cooperation in the Sahel region, West Africa and the Horn of Africa (Motion adopted): 427 For, 128 Against, 140 Abstention, 147 Did not vote (842 Members). Ewa Kopacz: For.

The EU’s role in protecting and restoring the world’s forests (Motion adopted): 543 For, 47 Against, 109 Abstention, 145 Did not vote (844 Members). Ewa Kopacz: For.

Conclusions of the extraordinary European Council meeting of 17-21 July 2020 (Motion adopted): 465 For, 150 Against, 67 Abstention, 155 Did not vote (837 Members). Ewa Kopacz: For.

European Parliament recommendation to the Council and the Commission concerning the conclusion of an agreement, under negotiation, between the European Union and New Zealand on the exchange of personal data between the European Union Agency for Law Enforcement Cooperation (Europol) and the New Zealand authorities competent for fighting serious crime and terrorism (Motion adopted): 438 For, 133 Against, 17 Abstention, 211 Did not vote (799 Members). Ewa Kopacz: Did not vote.

Amending Regulation (EU) 2016/1628 as regards its transitional provisions in order to address the impact of COVID-19 crisis (Motion adopted): 653 For, 17 Against, 11 Abstention, 157 Did not vote (838 Members). Ewa Kopacz: Did not vote.

The EU’s public health strategy post-COVID-19 (Motion adopted): 526 For, 105 Against, 50 Abstention, 157 Did not vote (838 Members). Ewa Kopacz: Did not vote.

A chemicals strategy for sustainability (Motion adopted): 579 For, 18 Against, 84 Abstention, 157 Did not vote (838 Members). Ewa Kopacz: Did not vote.

A comprehensive Union policy on preventing money laundering and terrorist financing – the Commission's Action plan and other recent developments (Motion adopted): 534 For, 25 Against, 122 Abstention, 157 Did not vote (838 Members). Ewa Kopacz: Did not vote.

Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (Motion adopted): 505 For, 67 Against, 109 Abstention, 157 Did not vote (838 Members). Ewa Kopacz: Did not vote.

Revision of the guidelines for trans-European energy infrastructure (Motion adopted): 548 For, 100 Against, 40 Abstention, 152 Did not vote (840 Members). Ewa Kopacz: For.

A comprehensive European approach to energy storage (Motion adopted): 556 For, 22 Against, 110 Abstention, 152 Did not vote (840 Members). Ewa Kopacz: For.

Objection to the Draft Commission Implementing Regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (D067115-02) (Motion adopted): 415 For, 252 Against, 20 Abstention, 153 Did not vote (840 Members). Ewa Kopacz: Against.

Guidelines for the employment policies of the Member States (Motion adopted): 550 For, 128 Against, 10 Abstention, 152 Did not vote (840 Members). Ewa Kopacz: For.

Amending budget no 5 to the general budget 2020 Continuation of the support to refugees and host communities in response to the Syria crisis in Jordan, Lebanon and Turkey (Motion adopted): 557 For, 72 Against, 59 Abstention, 152 Did not vote (840 Members). Ewa Kopacz: For.

Mobilisation of the Contingency Margin in 2020 to continue humanitarian support to refugees in Turkey (Motion adopted): 553 For, 106 Against, 29 Abstention, 152 Did not vote (840 Members). Ewa Kopacz: For.

Financial activities of the European Investment Bank - annual report 2019 (Motion adopted): 527 For, 73 Against, 91 Abstention, 151 Did not vote (842 Members). Ewa Kopacz: For.